Athanor Capital, LP Sarepta Therapeutics, Inc. Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $142,043 - $332,155	-1,966 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $1.21 Million - $1.72 Million	-9,645 Reduced 83.07%	1,966 $335,000
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $956,323 - $1.3 Million	7,523 Added 184.03%	11,611 $1.63 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $380,184 - $701,909	4,088 New	4,088 $655,000

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.